Homogeneous Catalysts for Hydrogenative PHIP Used in Biomedical Applications

用于生物医学应用的氢化PHIP均相催化剂

阅读:1

Abstract

At present, two competing hyperpolarization (HP) techniques, dissolution dynamic nuclear polarization (DNP) and parahydrogen (para-H(2)) induced polarization (PHIP), can generate sufficiently high liquid state (13)C signal enhancement for in vivo studies. PHIP utilizes the singlet spin state of para-H(2) to create non-equilibrium spin populations. In hydrogenative PHIP, para-H(2) is irreversibly added to unsaturated precursors, typically in the presence of a homogeneous catalyst. The hydrogenation catalyst plays a crucial role in converting the singlet spin order of para-H(2) into detectable nuclear polarization. Currently, rhodium(I) bisphosphine complexes are the most widely employed catalysts for PHIP, capable of catalyzing the addition of para-H(2) to unsaturated precursors in organic solvents or aqueous media, depending on the ligand. Chiral catalysts enable the stereoselective production of hyperpolarized substrates. Ruthenium(II) piano stool complexes are capable of trans addition and are used to generate hyperpolarized fumarate. However, these catalysts systems are not optimal, and the greatest source of nuclear spin polarization loss is attributed to the mixing of singlet and triplet states of the protons derived from the para-H(2) during the hydrogenation process. Hence, future efforts should focus on enhancing the efficiency and kinetics of these catalysts.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。